摘要
糖尿病现已成为继肿瘤、心血管疾病之后第三大威胁人类健康的慢性非传染性疾病,其发病率逐年剧增。据世界卫生组织2011年的统计数据,全球糖尿病患者已达3.66亿人。我国新近的流行病学调查资料显示,20岁以上人群糖尿病患病率达9.7%,而糖尿病前期的患病率高达15.5%,按此估算,目前我国约有9200万糖尿病患者,1.48亿糖尿病前期患者[1]。
出处
《中国医学前沿杂志(电子版)》
2012年第9期1-5,92,共5页
Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金
四川省科技厅支撑计划(2011SZ0215
2012SZ0027)
参考文献22
-
1Yang W,Lu J,Weng J. Prevalence of diabetes among men and women in China[J].New England Journal of Medicine,2010,(12):1090-1101.
-
2Bakris GL,Kuritzky L. Monitoring and managing urinary albumin excretion:practical advice for primary care clinicians[J].Postgraduate Medicine,2009,(04):51-60.
-
3Keane WF,Zhang Z,Lyle PA. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy:the RENAAL study[J].Clin J Am Soc Nephrol,2006,(04):761-767.
-
4Keane WF,Brenner BM,de Zeeuw D. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy:the RENAAL study[J].Kidney International,2003,(04):1499-1507.
-
5Karalliedde J,Viberti G. Proteinuria in diabetes:bystander or pathway to cardiorenal disease[J].Journal of the American Society of Nephrology,2010,(12):2020-2027.
-
6Lambers Heerspink HJ,Gansevoort RT,Brenner BM. Comparison of different measures of urinary protein excretion for prediction of renal events[J].Journal of the American Society of Nephrology,2010,(08):1355-1360.
-
7Babazono T,Nyumura I,Toya K. Higher levels of urinary albumin excretion within the normal range predict faster decline in glomerular filtration rate in diabetic patients[J].Diabetes Care,2009,(08):1518-1520.
-
8Hara M,Yamagata K,Tomino Y. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes:establishment of a highly sensitive ELISA to detect urinary podocalyxin[J].Diabetologia,2012.
-
9Narita T,Fujita H,Koshimura J. Glycemic control reverses increases in urinary excretions of immunoglobulin G and ceruloplasmin in type 2 diabetic patients with normoalbuminuria[J].Hormone and Metabolic Research,2001,(06):370-378.
-
10Togashi Y,Miyamoto Y. Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats[J].Experimental and Toxicologic Pathology,2012.
同被引文献33
-
1Zhang L, Wang F, Wang L, et al. Prevalence of chronic kid- ney disease in China: a cross-sectional survey [J ]. Lancet, 2012, 379(9818): 815-822.
-
2KDOQI. KIX)QI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease[J]. Am J Kidney Dis, 2007, 49(2 Suppl 2): S12- S154.
-
3Kramer HJ, Nguyen QD, Curhan G, et al. Renal insufficien- cy in the absence of albuminuria and retinopathy among adults with type 2diabetes mellitus [J]. JAMA, 2003, 289 (24): 3273-3277.
-
4Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy[J]. J Am Soe Nephrol, 2010, 21(4): 556-563.
-
5Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy[J]. J Am Soc Nephrol, 2010, 21 (4) : 556-563.
-
6Kidney Disease: Improving Global? Outcomes (KD1GO). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int Suppl, 2013, 3: pp 1-150.
-
7National Kidney Foundation. KDOQI Clinical Practice Guide- line for Diabetes and CKD.. 2012 Update[J]. Am J Kidney Dis, 2012, 60(5): 850-886.
-
8ERA-EDTA. Clinical Practice Guideline on management of pa- tients with diabetes and chronic kidney disease stage 3b or higher (eGFR45 mL/min) [J]. Nephrol Dial Transplant, 2015, 30(Suppl 2) : iil-ii142.
-
9Freedman BI, Andries L, Shihabi ZK, et al. Glycated albu- min and risk of death and hospitalizations in diabetic dialysis patients[J]. Clin J Am Soc Nephrol, 2011, 6(7) : 1635-1643.
-
10Peacock TP, Shihabi ZK, Bleyer AJ, et al. Comparison of glycated albumin and hemoglobin A(lc) levels in diabetic sub- jects on hemodialysis[J]. Kidney Int, 2008, 73(9): 1062- 1068.
二级引证文献12
-
1曾福英,蒋伟勇,张秋梅.RBP、CysC、sICAM-1、u-MALB联合检测对早期糖尿病肾病的诊断价值[J].热带医学杂志,2019,19(1):35-38. 被引量:27
-
2孙树果,张继超,秦萌.维生素D3注射液联合黄葵胶囊治疗糖尿病肾脏病早期白蛋白尿的疗效观察[J].临床肾脏病杂志,2018,18(9):542-545. 被引量:5
-
3王大鹏,高萍.血液灌流联合序贯透析对终末期糖尿病肾病患者胰岛素抵抗及微炎症状态的影响[J].中国医学前沿杂志(电子版),2018,10(1):87-90. 被引量:10
-
4龙海涛.依那普利联合羟苯磺酸钙辅助胰岛素强化干预治疗老年早期糖尿病肾病的临床观察[J].现代诊断与治疗,2018,29(20):3195-3196. 被引量:1
-
5喻敏,刘春雅,罗林峰,陈忆琳.血清同型半胱氨酸、胱抑素C和尿足细胞检测在Ⅱ型糖尿病肾病的早期诊断中的作用分析[J].中国卫生检验杂志,2019,29(16):1984-1986. 被引量:11
-
6梁维,赵静,冯玲,何志婷,秦书敏.磁共振IVIM技术对T2DM肾病患者肾功能的评价价值[J].中国CT和MRI杂志,2019,17(12):81-83. 被引量:8
-
7崔雯,姜慧英,李婕,王鹏飞,赵金凤,白冰,董磊,马红雨.糖化白蛋白在糖尿病及糖尿病肾病诊断中的临床意义[J].中国实用医药,2020,15(9):1-4. 被引量:5
-
8张雪,张旋乾,黄蕊.MSCT灌注成像在糖尿病肾病诊断中的意义[J].中国CT和MRI杂志,2020,18(4):97-100. 被引量:7
-
9冯莉,杨静,郭年春,高艳山,张丽华.福辛普利联合氯沙坦治疗2型糖尿病肾病的效果观察及对血管内皮功能的影响[J].解放军医药杂志,2020,32(7):63-67. 被引量:7
-
10英鹏东.中医药治疗糖尿病肾病的研究进展[J].中医临床研究,2021,13(26):127-130. 被引量:5
-
1郑春松,张耐茹.糖尿病教育对胰岛素治疗依从性的影响[J].中国现代药物应用,2007,1(1):56-57.
-
2导读前线[J].医疗保健器具(保健器具版),2004(2):1-1.
-
3糖尿病可以预防吗?[J].医学文选,1994(4):12-13.
-
4萧建中.危重症患者高血糖处理[J].中华糖尿病杂志,2009,1(5).
-
5糖尿病病人增长最快国家中国排第二[J].家庭健康(医学科普),2006(4):32-32.
-
6王姮.第二届中日友好糖尿病研究交流会[J].国外医学情报,1990(2):17-18.
-
7钱庆.快餐食品使加州的肥胖症和糖尿病患者增多[J].国外医学情报,1999(12):38-38. 被引量:1
-
8辛木.养生是健康人的防病方法也是患病者之治疗基础[J].健康大视野,2010(19):44-44.
-
9邵加庆.局部肾素-血管紧张素系统在2型糖尿病中的作用[J].医学研究生学报,2011,24(5):449-452. 被引量:11
-
10段振离.糖尿病患者的药膳[J].开卷有益(求医问药),2002(2):5-5.